Close

CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference Sep 28, 2021 08:00AM
CRISPR Therapeutics (CRSP) PT Lowered to $171 at Chardan Capital Markets Jul 30, 2021 07:53AM
CRISPR Therapeutics (CRSP) PT Raised to $166 at Chardan Capital Markets Dec 10, 2020 08:07AM
CRISPR Therapeutics to Participate in Upcoming Investor Conferences Sep 29, 2020 08:00AM
CRISPR Therapeutics (CRSP) Prices 4.25M Share Common Offering at $64.50/Sh Nov 21, 2019 05:52AM


Nov 20, 2019 09:18PM CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
Oct 28, 2019 10:25AM Chardan Capital Markets Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
Oct 1, 2019 07:00AM CRISPR Therapeutics to Present at Upcoming Investor Conferences
Jan 22, 2019 09:28AM Pre-Open Stock Movers 01/22: (EBAY) (UAA) (PANW) Higher; (ARNC) (PETS) (SWK) Lower (more...)
Oct 2, 2018 07:00AM CRISPR Therapeutics to Present at the Chardan Genetic Medicines Conference
May 15, 2018 06:33AM CRISPR Therapeutics (CRSP) PT Raised to $72.50 at Chardan Capital Markets 'on the Chardan Gene Editing Framework'
Oct 4, 2017 04:01PM CRISPR Therapeutics to Present at Investor Conferences in October
Mar 27, 2017 04:33PM Chardan Capital Markets Starts CRISPR Therapeutics (CRSP) at Buy